title: [Sacubitril-valsartan is a new cornerstone in heart failure therapy].
authors.affiliation: Karolinska Institutet - Department of Medicine Stockholm, Sweden Karolinska Institutet - Department of Molecular Medicine and Surgery Stockholm, Sweden.
authors.forename: Lars H
authors.initials: LH
authors.lastname: Lund
authors.affiliation: Goteborgs universitet Sahlgrenska Akademin - Medicin-Akut-Geriatrik Goteborg, Sweden Goteborgs universitet Sahlgrenska Akademin - Medicin-Akut-Geriatrik Goteborg, Sweden.
authors.forename: Michael
authors.initials: M
authors.lastname: Fu
authors.affiliation: Sahlgrenska Akademin - Avdelningen för molekylär och klinisk medicin Göteborg, Sweden Sahlgrenska Akademin - Avdelningen för molekylär och klinisk medicin Göteborg, Sweden.
authors.forename: Karl
authors.initials: K
authors.lastname: Swedberg
mesh_terms: D000613:Aminobutyrates / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D013548:Sweden; D013777:Tetrazoles / Q000627:therapeutic use*; D000068756:Valsartan
chemical_list: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D000068756:Valsartan; C549068:sacubitril and valsartan sodium hydrate drug combination